Skip to main content

Year: 2020

Flex LNG Q3, 2020 Earnings Release

November 17, 2020 – Hamilton, BermudaFlex LNG Ltd. (“Flex LNG” or the “Company”) today announced its unaudited financial results for the third quarter and nine months ended September 30, 2020.Highlights:Revenues of $33.1 million for the third quarter 2020, compared to $25.8 million for the second quarter 2020.Net income of $3.8 million and earnings per share of $0.07 for the third quarter 2020, compared to a net loss of $6.7 million and loss per share of $0.12 for the second quarter 2020.Average Time Charter Equivalent (“TCE”) rate of $46,569 per day for the third quarter 2020, compared to $46,588 per day for the second quarter 2020.Adjusted EBITDA of $21.9 million for the third quarter 2020, compared to $17.4 million for the second quarter 2020.Adjusted net income of $1.2 million for the third quarter 2020,...

Continue reading

Innate Pharma reports third quarter 2020 financial results and business update

Lacutamab granted PRIME designation in Sézary Syndrome by the European Medicines AgencyMonalizumab Phase 3 study initiated, triggering $50 million milestone paymentCash position of €163.6 million1 as of September 30, 2020Marseille, Nov. 17, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced its revenues and cash position for the first nine months of 2020.“In November, we were very pleased that our lead proprietary asset, lacutamab, was awarded PRIME designation in Sézary Syndrome by the European Medicines Agency, which follows the US Fast Track designation by the FDA last year.  Lacutamab is an important part of our strategy to build a focused proprietary pipeline, and these regulatory milestones further validate the unmet need in this patient...

Continue reading

Press news Biocartis Group NV: Biocartis Announces Publication of Large Multi-Center Comparison Study with Idylla™ MSI Assay Showing Very Low Failure Rates and Excellent Concordance with Reference Methods

PRESS RELEASE17 November 2020, 07:00 CETBiocartis Announces Publication of Large Multi-Center Comparison Study with Idylla™ MSI Assay Showing Very Low Failure Rates and Excellent Concordance with Reference MethodsMechelen, Belgium, 17 November 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the publication of a global multi-center real world study1 with its Idylla™ MSI Assay. This multi-center study is the largest so far for Biocartis and demonstrates excellent performance of the Idylla™ MSI Assay2 with a very low failure rate.In this real-world global study, 44 clinical centers performed Idylla™ MSI testing on 1,301 archived colorectal cancer FFPE3 tissue sections. Idylla™ results were compared against routine diagnostic testing in those...

Continue reading

Persbericht Biocartis Group NV: Biocartis kondigt publicatie van grote vergelijkende multi-center studie aan met Idylla™ MSI Assay die zeer laag faalpercentage en uitstekende overeenstemming met referentiemethoden aantoont

PERSBERICHT17 november 2020, 07:00 CETBiocartis kondigt publicatie van grote vergelijkende multi-center studie aan met Idylla™ MSI Assay die zeer laag faalpercentage en uitstekende overeenstemming met referentiemethoden aantoontMechelen, België, 17 november 2020 – Biocartis Group NV (de ‘Vennootschap’ of ‘Biocartis’), een innovatief bedrijf in de moleculaire diagnostiek (Euronext Brussels: BCART), kondigt vandaag de publicatie aan van een  wereldwijde ‘real-world’ multi-center study1 met zijn Idylla™ MSI Assay. Deze multicenter studie is de grootste tot nu toe voor Biocartis en toont uitstekende performantie van de Idylla™ MSI Assay2 met een zeer laag uitvalspercentage.In deze real-world wereldwijde studie voerden 44 klinische centra Idylla™ MSI testing uit op 1.301 gearchiveerde FFPE3 weefselsecties van colorectale (darm)kanker. De resultaten...

Continue reading

Innate Pharma présente ses résultats financiers et l’avancée de son portefeuille au troisième trimestre 2020

Lacutamab a reçu le statut « PRIME » de l’Agence Européenne du Médicament dans le syndrome de SézaryLe démarrage de la Phase 3 de monalizumab déclenche un paiement d’étape de 50 millions de dollarsTrésorerie, équivalents de trésorerie et actifs financiers s’élevant à 163,6 millions d’euros au 30 septembre 20201Marseille, 17 nov. 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui son chiffre d’affaires et sa position de trésorerie pour les neuf premiers mois de l’année 2020.« En novembre, nous avons été très satisfaits que lacutamab, notre produit propriétaire le plus avancé, reçoive le statut PRIME de l’Agence Européenne du Médicament dans le syndrome de Sézary. Cette annonce est consécutive à l’attribution du statut « Fast Track »...

Continue reading

GROUPE PARTOUCHE : Avec PASINO.ch, le Groupe Partouche lance son casino en ligne sur le marché suisse

Avec PASINO.CH, le Groupe Partouchelance son casino en ligne sur le marché suisseParis, le 17 novembre 2020, à 7hPASINO.ch propose dans les trois langues nationales et en anglais une large gamme de jeux innovants.Avec PASINO.ch, le Groupe Partouche élargit ainsi son éventail de produits et renforce son leadership dans son secteur d’activité.Conçue comme le prolongement du Casino du Lac Meyrin (Genève), PASINO.ch invite les joueurs résidant en Suisse à découvrir en ligne son offre complète de jeux de Casino en argent réel, ses machines à sous et son univers de tables de jeux avec croupiers en direct.Cette offre en ligne réglementée par la Commission fédérale suisse des maisons de jeu (CFMJ), entend offrir une expérience unique, tant par son service clientèle premium accessible 24/7 que par son environnement innovant et sécurisé.PASINO.ch...

Continue reading

Flex LNG Third Quarter 2020 Presentation

Flex LNG Third Quarter 2020 PresentationPlease find enclosed the presentation of Flex LNG Ltd.’s third quarter 2020 results to be held through webcast/conference call November 17, 2020 at 3:00 p.m. CET (9:00 a.m. EST)Attend by Webcast:Use to the follow link prior to the webcast:https://edge.media-server.com/mmc/p/noymzjrhAttend by Conference Call:Applicable dial-in telephone numbers are as follows:Norway: +47 21 03 39 22United Kingdom: +44 (0) 203 0095 709United Kingdom (local): 0844 4936 766United States (Toll Free): +1 866 2801 157Confirmation Code: 5888874The presentation material which will be used in the teleconference/webcast can be downloaded on www.flexlng.com and replay details will also be available at this website.AttachmentFlex LNG Q3 2020 Presentation_vF

Continue reading

GWTI Responds to RRC Gas Flaring Reduction Moves – Update

ARLINGTON, Texas, Nov. 17, 2020 (GLOBE NEWSWIRE) — Greenway Technologies, Inc. (OTCQB: GWTI), (the “Company”), an advanced gas-to-liquids (“GTL”) technology development company, today responds to the November 4, 2020 Texas Railroad Commission (RRC) announcement aimed at further reducing flaring from oil and gas sites across the state.The agency’s commissioners announced approval of revamped exceptions associated with Statewide Rule 32 which states that “all gas from any oil well, gas well, gas gathering system, gas plant or other gas handling equipment shall be utilized for purposes and uses authorized by law.”RRC commissioners approved a revamped Form R-32 used for exceptions to Rule 32. Among the changes are a reduction in the period of time for a flaring exception, and incentives for operators that deploy technologies to reduce...

Continue reading

Grieg Seafood releases third quarter 2020 results and presents plan for enhanced value creation

Today, Grieg Seafood ASA releases its report for the third quarter 2020. At the same time, the company presents an update on its ambitions, strategy and priorities in a capital markets update.Third quarter highlightsHarvest volume of 21 201 tonnes (21 028 tonnes in Q3 2019)Negative EBIT before fair value adjustment of NOK 192 million (+143 million)Negative EBIT/kg of NOK 9.0 (+6.8)Disrupted markets with low spot prices had a negative impact by NOK 92 million on earnings in the quarter compared to corresponding quarter in 2019Good performance in Rogaland and Finnmark, total EBIT/kg NOK 9.9 (11.2)Shetland profitability negatively impacted by NOK 150 million from Skye and Grieg Seafood decided to cease its operations on Isle of SkyeCommenting on the company’s performance in Q3, CEO Andreas Kvame, said:“The third quarter was challenging for...

Continue reading

eXp World Holdings Expands Real Estate Operations Into India

BELLINGHAM, Wash., Nov. 17, 2020 (GLOBE NEWSWIRE) — eXp World Holdings (Nasdaq: EXPI), the holding company for eXp Realty, one of the fastest-growing residential and commercial real estate companies in the world, today announced it has expanded its collaborative, cloud-based real estate brokerage model into India, under the eXp India banner. The addition of residential and commercial brokerage operations in India represents the fifth international expansion for the company, which is headquartered in the United States. In addition to its robust U.S. presence, eXp Realty also operates in Canada, the United Kingdom, Australia, and South Africa, with more than 38,000 agents across the globe.eXp Realty offers a unique financial model for residential and commercial real estate agents, going beyond attractive commissions to provide its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.